Krankenhaus Muenchen Schwabing
Munich, Germany
Hospital department in Munich, Bavaria
Kölner Platz 1 Haus 13, 1. OG, 80804 München
About Krankenhaus Muenchen Schwabing
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
German CLL Study Group
8
University of Ulm
4
German High-Grade Non-Hodgkin's Lymphoma Study Group
3
Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany
3
Biotronik AG
1
Edwards Lifesciences
1
European Inter-group Cooperation on Childhood and Adolescent Non Hodgkin Lymphoma
1
Genentech, Inc.
1
German Hodgkin's Lymphoma Study Group
1
Gilead Sciences
1
III. Medizinische Klinik Mannheim
1
Clinical Trials at Krankenhaus Muenchen Schwabing
During the past decade, Krankenhaus Muenchen Schwabing conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on
average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Chemotherapy and Biological Therapy With or Without Bone Marrow or Peripheral Stem Cell Transplant in Treating Patients With Chronic Myelogenous Leukemia
1997-07-01
Unknown status
1,000
Combination Chemotherapy and Peripheral Stem Cell Transplant in Treating Patients With Relapsed Hodgkin's Lymphoma
2001-07-01
Unknown status
220
Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma
2001-01-01
2010-08-05
Completed
1,506
Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma
2002-04-01
2006-12-05
Completed
392
Observation of Young Patients Who Are Undergoing Surgery for Craniopharyngioma
2001-05-01
2009-09-01
Completed
120
Fludarabine or Observation in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia
1997-04-01
2010-06-01
Completed
877
Fludarabine or Chlorambucil as First-Line Therapy in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia
2003-09-01
2005-10-01
Completed
206
Cyclophosphamide and Total Body Irradiation in Treating Patients Who Are Undergoing an Autologous Peripheral Stem Cell Transplant For Chronic Lymphocytic Leukemia
1998-01-01
2012-04-01
Completed
169
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Krankenhaus Muenchen Schwabing" #1 sponsor was "German CLL Study Group" with 8 trials, followed by "University of Ulm" with 4 trials
sponsored, "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 3 trials sponsored, "Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany" with 3 trials sponsored and "Biotronik AG"
with 3 trials sponsored. Other sponsors include 6 different institutions and
companies that sponsored additional 16 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Krankenhaus Muenchen Schwabing"
#1 collaborator was "AbbVie" with 2 trials as a collaborator, "Cancer Trials Ireland" with 2 trials as a collaborator, "German CLL Study Group" with 2 trials as a collaborator, "Janssen-Cilag Ltd." with 2 trials as a collaborator and "Nordic CLL Study Group (NCLLSG)" with 2 trials as a collaborator. Other collaborators include 30 different institutions and companies that were
collaborators in the rest 40 trials.
Clinical Trials Conditions at Krankenhaus Muenchen Schwabing
According to Clinical.Site data, the most researched conditions in "Krankenhaus Muenchen Schwabing" are
"Chronic Lymphocytic Leukemia" (8 trials), "Lymphoma" (6 trials), "Leukemia" (3 trials), "Acute Myeloid Leukemia" (2 trials) and "Chronic Lymphoid Leukemia" (2 trials). Many other conditions were trialed in "Krankenhaus Muenchen Schwabing" in a lesser frequency.
Clinical Trials Intervention Types at Krankenhaus Muenchen Schwabing
Most popular intervention types in "Krankenhaus Muenchen Schwabing" are "Drug" (23 trials), "Biological" (14 trials), "Radiation" (10 trials), "Procedure" (7 trials) and "Device" (2 trials). Other intervention types were less common.
The name of intervention was led by "cyclophosphamide" (9 trials), "radiation therapy" (9 trials), "filgrastim" (7 trials), "vincristine sulfate" (7 trials) and "Obinutuzumab" (6 trials). Other intervention names were less common.
Clinical Trials Genders at Krankenhaus Muenchen Schwabing
The vast majority of trials in "Krankenhaus Muenchen Schwabing" are
30 trials for "All" genders.
Clinical Trials Status at Krankenhaus Muenchen Schwabing
Currently, there are NaN active trials in "Krankenhaus Muenchen Schwabing".
undefined are not yet recruiting,
3 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 18 completed trials in Krankenhaus Muenchen Schwabing,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Krankenhaus Muenchen Schwabing, 1 "Phase 1"
clinical trials were conducted, 7 "Phase 2" clinical
trials and 15 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 4 trials that are defined as “Not Applicable".